4 th Annual Clinical Development and Trials Asia Congress. 5 th Annual Pharma R&D World Asia Congress
|
|
- Jessie Stanley
- 7 years ago
- Views:
Transcription
1 Oxford Global Medical Conferences Imaging technologies are proud to present the 4 th Annual Clinical Development and Trials Asia Congress and Implementing biomarkers in co-located early phase Pharma clinical trials R&D Asia Congress to be held on the 27 th Development & 28 th January of Companion 2015 in Shanghai, Diagnostics China. Clinical Attended Trials by over 170 industry leaders in Clinical Development & Clinical Trials Development Managing in Safety Asia, and the Efficacy 4 th Annual Clinical Development and Trials Asia Congress will offer invaluable insights on successful strategies and technologies in enabling clinical development, clinical outsourcing strategies and clinical trial management. On day one hear from senior VPS and Directors in discussing clinical development strategies as well as clinical development in oncology and other therapeutic areas in China, Japan, South Korea, India, & Singapore. It will also cover key discussion on the changing regulatory environment in China and impact of this on multinational drug development activities. Do not miss out on updates in registration for multinational clinical trials and international regulatory updates including FDA breakthrough regulation, EMA RMP regulation There is also a featured enabling technologies stream dedicated to managing Clinical Development, implementing Biomarkers into Drug & clinical research, translational science and Clinical Data Management. Day two will focus on Clinical Trial Management strategies for minimising costs, bridging studies in Asia for Global Development, Safety and Pharmacovigilance and risk management. The 4 th Annual Pharma R&D World Asia congress will discuss novel scientific innovations in Discovery and Development in Asia. Topics will cover: global collaboration, changes in the model of CRO outsourcing & partnering strategies, regulation policies and drug innovation strategies. Our esteemed experts will discuss strategies to accelerate drug development timelines. 4 th Annual Clinical Development and Trials Asia Congress Day 1 Clinical Development Activities & Clinical Outsourcing Strategies Regional clinical development activities in Asia and Asia Pacific regions - China, Japan, South Korea & Singapore Clinical development activities in oncology and other therapeutic areas Selecting the correct Pharma CRO partnership for maximum success Changing regulatory environment in China and impact of this on multinational drug development activities Regulatory updates for Registration for Multinational Clinical Trials China, Japan, South Korea & Singapore Day 1 - Featured Technology Stream Enabling Technologies for Drug Development and Personalised Medicine Imaging biomarkers: bridging preclinical and clinical research Medical Imaging technologies Implementing biomarkers in early phase clinical trials Development of Companion Diagnostics in Clinical Trials Biometrics in Asia Pacific Clinical Trials Clinical Data Management Day 2 Clinical Trials Management Strategies in Asia and Asia Pacific Regions Implementing successful patient recruitment and retention strategies Opportunities of bridging studies in Asia for Global Development Country and site selection for global clinical trials Managing clinical trials in oncology and other therapeutic areas Ensuring pharmacovigilance and patient safety in clinical trials in Asia Managing Safety and Efficacy VP and Director Panel Discussion Topics PANEL 1: Will Asia Produce in Regards to Drug Development PANEL 2: Regulatory updates for Registration for Multinational Clinical Trials China, Japan, South Korea & Singapore PANEL 3: Innovation Strategies to Advance R&D in Asia PANEL 4: CRO - R&D Collaborations and Business Models 5 th Annual Pharma R&D World Asia Congress Day 1 - Innovation Strategies to Advance R&D in Asia R&D collaborations between East & West Guaranteeing successful outsourcing partnerships Successful business models in CRO partnership Multi-national pharma companies in emerging markets International regulatory updates including FDA breakthrough regulation, EMA RMP regulation Targeted Therapy & Molecular Targeted Drugs Drug development in oncology and other therapeutic areas Novel methods to accelerate drug development pipeline In licensing strategies
2 Clinical Asia and R&D Asia Confirmed Speakers 2015: Zhengqing Li, VP and Head of China Development MSD Cezary Statuch, Vice President of R&D, Bristol-Myers Squibb, China Dan Paulson, Vice President, Global Clinical Development, Group Head, Cardiovascular Risk Management and Women s HealthCare, Bayer HealthCare Company Limited Global R&D Centre Oliver Kong, Senior Director, Clinical Development Oncology, Celgene Corporation Akhilesh Sharma, Senior Vice President & Global Head Global Medical Affairs, Dr. Reddy's Laboratories India Victoria Elegant, Vice President of Medical & Regulatory Affairs, Baxter, China Dejun Tang, Site Head, Biometrics & Statistical Sciences and Methodology. Novartis, China Wei Wang, Associate Director, Safety Surveillance and Risk Management, Pfizer, China Yong-jiang Hei, Executive Medical Director, Amgen China Jagdev Sidhu, Senior Director Clinical Pharmacology & Pharmacometrics,CSL Limited Patrecia Valone, Senior Director, Development Operations, Takeda Development Center Asia and Takeda Shanghai Development Center Hua Mu, Senior Vice President, Global Head of Product Development Service and Partnership Business Unit, WuXi AppTec (Shanghai) Co., Ltd Jessie Gu, Head, Translational Medicine China, Novartis Institute for Biomedical Research, China Ming Ji, Sr. Medical Director, Medical Safety Evaluation, AbbVie Jason Yang, Senior Vice President, Head of Clinical Development, BeiGene(Beijing)Co., Ltd Yingmei Tu, Clinical Research Director, Merck Ralf Altmeyer, Director General, Institut Pasteur Shanghai, Chinese Academy of Sciences Yan Wu, Executive Director, Head of Clinical Operations and Drug Safety, Hutchison Medi Pharma Jennifer Huang Executive Director, Head of Global Clinical Trial Operations, Merck Research Laboratories R&D (China) Ltd Jingsong Wang, Head of China R&D, Head of Translational Medicine, Asia Pacific, Sanofi Chih-Liang Chin, Director and Site Lead, Imaging, Merck Singapore Frank Grams, VP, Head Alliance Management & Transactions, Sanofi R&D David Tattersall, Director, Neurodegeneration Parkinson's Disease Group, GSK R&D China Shanghai Mingde Xia, Senior Director, Johnson & Johnson Innovation Center, Asia Pacific Jenny Wei, Head of R&D Information Asia & EM, Innovation Center China, AstraZeneca Global R&D Zheng Li, General Manager, Head of Research China, Lundbeck Jun Bao, Senior Vice President and Chief Business Officer, Shenogen Pharma Group Jian Li, Director, Partnering and External Innovation - Asia Pacific, Sanofi R&D Yariv Hefez, Vice President Business Development, Portfolio Management, Strategy and Partnering, Biosimilars Unit, Merck Zhenping Wu, Senior Vice President, Pharmaceutical Sciences, Hutchison Medi Pharma Ming Guo, Co-Founder & COO, Ascentage Pharma Amar Kureishi, Chief Medical Officer and Head of Drug Development, Quintiles Asia Event Sponsor:
3 Hear from our 2015 Speakers: Cezary Statuch BMS Zhengqing Li MSD Yong Hei Amgen David Tattersall GSK Jingsong Wang Sanofi Patrecia Valone Takeda Jagdev Sidhu CSL Akhilesh Sharma Dr Reddy s Lab Who You Will Meet 175 senior attendees from leading academic institutions, pharmaceutical organisations and biotechnology companies will be attending. Meet VPs, Directors & Senior Managers with the following job titles: Clinical Research Clinical Biomarkers Clinical Supply Chain Safety In licensing Clinical Outsourcing Clinical Trial Management Personalised Medicine Regulatory Affairs Business Development Clinical Operations Clinical Development Translational Medicine Preclinical Development Biomarkers Patient Safety Medical Affairs Research and Development Discovery Data Management Networking And Business Meeting Opportunities Meet face-to-face with leading solution providers and senior-level industry peers through a series of formal and informal networking opportunities. Categories of solution provider include: Clinical Testing Supply Chain Management Cold Chain Management PKPD Clinical Trial Design Regulatory Compliance Outsourcing Strategies Imaging Solutions & Management Translational Research Companion Diagnostics Discovery Solutions Assay Development Patient Selection Biomarker solutions Data Management Biometric
4 4 th Annual Clinical Asia Congress & 5 th Annual Pharma R&D Asia Congress Day One 27 th January Registration: The Atrium Conference Room: New Asia Ballroom 1 - Oxford Global s Welcome Address Chairperson s Opening Address Directors and VPs Panel Discussions Directors and VPs Panel Discussion Will Asia Produce in Regards to Drug Development Drug development in Asia is undergoing significant changes these days (regulatory, clinical, operational, etc.) and many companies are now experiencing a gap in terms of seeing results from significant investment in the region. Investments in infrastructure and development programs in Asia (sites and patients) have been made. The panel will discuss challenges in the productivity of sites, quality of production, and the changing regulatory environment in China, and will also rethink Development strategies for Multinationals.. Confirmed Panel Moderator: Dan Paulson, Vice President, Global Clinical Development, Group Head, Cardiovascular Risk Management and Women s HealthCare, Bayer HealthCare Company Limited Global R&D Centre Confirmed Panel: Cezary Statuch, Vice President of R&D, Bristol-Myers Squibb, China Akhilesh Sharma, Senior Vice President & Global Head Global Medical Affairs, Dr. Reddy's Laboratories India Yong-jiang Hei, Executive Medical Director, Amgen China Zhengqing Li, VP and Head of China Development, MSD Directors and VPs Panel Discussion Changing Regulatory Environment in China and Impact of this on Multinational Drug Development Activities Confirmed Panel Moderator: Cezary Statuch, Vice President of R&D, Bristol-Myers Squibb, China Confirmed Panel: Victoria Elegant, Vice President of Medical & Regulatory Affairs, Baxter, China Michael Rozycki, Vice President, Regulatory Affairs Asia Pacific, Allergan (TBA) Ming Guo, Co-Founder & COO, Ascentage Pharma Innovation Strategies to Advance R&D in China and Asia Open Innovation / Collaboration Strategy (east-west, academia-industry, company-company, private-public, incubator, consortium, co-investment, etc). Collaboration models (PPP, risk sharing) Innovation Strategies to boost China as a global R&D center Successful business models in Pharma R&D The role of MNC vs local companies in developing China as a Global R&D source What does the future hold, China in 2024 Panel Moderator: Jingsong Wang, Head of China R&D, Head of Translational Medicine, Asia Pacific, Sanofi Confirmed Panel: Mingde Xia, Senior Director, Johnson & Johnson Innovation Center, Asia Pacific Zheng Li, General Manager, Head of Research China, Lundbeck Jian Li, Director, Partnering and External Innovation - Asia Pacific, Sanofi R&D Yariv Hefez, Vice President Business Development, Portfolio Management, Strategy and Partnering, Biosimilars Unit, Merck Jun Bao, Senior Vice President and Chief Business Officer, Shenogen Pharma Group Directors and VPs Panel Discussion R&D Collaborations - The Changing Nature of CRO and Sponsor Relationships Type of R&D collaboration how the CRO is changing their model of support for domestic local clients and multinational clients Are the collaboration/business models different for China based clients versus that of other regions Training and dealing with workforce to sustain success in collaborations
5 CRO - innovative models of service offerings Selecting the Right Pharma CRO partnership for Maximum Success Confirmed Panel: Frank Grams, VP, Head Alliance Management & Transactions, Sanofi R&D David Tattersall, Director, Neurodegeneration Parkinson's Disease Group, GSK R&D China Shanghai Solution Provider Presentation For enquiries, please sponsorship@oxfordglobal.co.uk Exhibition Room: The Atrium Morning Coffee & Refreshments One to One Meetings x3 R&D Asia Congress Innovation Strategies to Advance R&D in Asia Clinical Asia Congress Clinical Development Activities & Clinical Research Outsourcing Strategies Enabling Technologies for Drug Development and Translational Medicine Conference Room: New Asia Ballroom 1 Conference Room: New Asia Ballroom 2 Conference Room 3: Stream Chair: Stream Chair: Stream Chair: New Drug Development, Global Health Trends and the Future of Bio-Pharma in Asia CONFIRMED: Amar Kureishi, Chief Medical Officer and Head of Drug Development, Quintiles Asia Solution Provider Presentation Global vs Local: Clinical Development, Clinical Trials & CRO Selection CONFIRMED: Yan Wu, Executive Director, Head of Clinical Operations and Drug Safety, Hutchison Medi Pharma Biomarkers in Early Clinical Development The key focus on early clinical development is achieve go vs. no go decision, early readout of intended pharmacological activities is critical. Well mapped biomarker strategy is must to have to achieve such goal. In addition of assessing pharmacological or intended biological activities, biomarker has been used routinely for patient selection and stratification. Validating and implementing biomarker strategy are essential for effective early development CONFIRMED: Zaiqi Wang, Head of Clinical Research, Merck, China Exhibition Room: The Atrium Lunch Hutchison Medi Pharma s Drug Development Pipeline and Innovation in China and other regions of Asia CONFIRMED: Zhenping Wu, Senior Vice President, Pharmaceutical Sciences, Hutchison Medi Pharma Regional Clinical Development in Asia and Asia Pacific Regions CONFIRMED: Yingmei Tu, Clinical Research Director, Merck Biomarker Development In Clinical Trials Design in Oncology CONFIRMED: Oliver Kong, Senior Director, Clinical Development Oncology, Celgene Corporation
6 Innovative Collaboration In Pharmaceutical R&D - managing our global network of alliances CONFIRMED: Frank Grams, VP, Head Alliance Management & Transactions Sanofi R&D Exploring and Applying Innovative Strategies and Models to Pursue Effective New Drug Development in China CONFIRMED: Hua Mu, Senior Vice President Global Head of Product Development Service and Partnership Business Unit, WuXi AppTec (Shanghai) Co., Ltd Implementing Biomarkers in Clinical Development in China CONFIRMED Jessie Gu, Head, Translational Medicine China, Novartis Institute for Biomedical Research, China Conference Room: New Asia Ballroom 1 Conference Room 2: New Asia Ballroom 2 Conference Room Drug Development in Asia - Regulatory Strategies and Clinical Plan Key Developments in Regional and Global Clinical Trial Activities & Clinical Research Outsourcing Strategies Regulatory Requirements Clinical plans for Global Clinical Studies CONFIRMED: Jason Yang, Senior Vice President, Head of Clinical Challenges and Opportunities CONFIRMED: Ralf Altmeyer, Director Development, BeiGene(Beijing) Co., Ltd General, Institut Pasteur Shanghai, Chinese Academy of Sciences Exhibition Room: The Atrium Afternoon Refreshments One to One Meetings x Development of Translational Imaging Biomarker for Drug Discovery and Development Leverage advanced imaging technologies to understand disease biology and validate novel therapeutic targets Develop biomarkers using multi-modality imaging approaches across species to de-risk clinical development Enable early GO/No-Go decisions using translational imaging biomarkers in animal models of human disease and humans. CONFIRMED: Chih-Liang Chin, Director and Site Lead, Imaging, Merck Singapore Cardiovascular Drug Development: Cardiogenomics and Asia, is there Potential for a Personalized Approach to Medical Care? CONFIRMED: Dan Paulson, Vice President, Global Clinical Development, Group Head, Cardiovascular Risk Management and Women s HealthCare, Bayer HealthCare Company Limited Global R&D Centre Companion Diagnostics Development in Both Preclinical and Clinical Context Tero Laulajainen, RPD Global Head of Clinical Operations, Roche Diagnostics International Ltd, Switzerland Biometrical Challenges in Asia Pacific Clinical Trials Current status of biometrics applications in clinical trials including Asia Quantitative trial design and decision making Challenges due to new innovations and health authority requirements Difference in challenges for global pharma and domestic ones Impact from big data and its applications CONFIRMED: Dejun Tang, Head of Integrated Information Sciences, Site Head, Biometrics & Statistical Sciences and Methodology. Novartis, China Exhibition Room: The Atrium Networking Drinks End of Day One
7 4 th Annual Clinical Asia Congress & 5 th Annual Pharma R&D Asia Congress Day Two 28 th January 2015 Clinical Asia Congress Conference Room 2: New Asia Ballroom Patient Recruitment Strategies: Does One Size Fit all Globally? Can learning from the global operations be translated into effective local strategy The inter-geography variations In patients factors impacting recruitment and retention Perceived differences by investigator s & patients between a generic and innovator product study impacting patient drop-outs Broad guidelines to improve patient retention in clinical trials across geographies CONFIRMED: Akhilesh Sharma, Senior Vice President & Global Head Global Medical Affairs, Dr. Reddy's Laboratories India Solution Provider Presentation For enquiries, please sponsorship@oxfordglobal.co.uk Exhibition Room: The Atrium Morning Coffee & Poster Presentations Poster Presentation Sessions Optimization of the Clinical Trial Conduct CONFIRMED: Jennifer Huang, Executive Director, Head of Global Clinical Trial Operations, Merck Research Laboratories R&D (China) Ltd Clinical Trials in Neurodegenerative Diseases especially Parkinson's Disease CONFIRMED: David Tattersall, Director, Neurodegeneration Parkinson's Disease Group, GSK R&D China Shanghai Developing Clinical Investigators and Sites in Asia & Pacific Region for Global Studies CONFIRMED: Jenny Wei, Head of R&D Information Asia & EM, Innovation Center China, AstraZeneca Global R&D Solution Provider Presentation Lunch - Exhibition Room: The Atrium An Alternative Perspective to Clinical Development: Challenging the Norm with Pharmacometrics CONFIRMED: Jagdev Sidhu, Senior Director Clinical Pharmacology & Pharmacometrics, CSL Limited Australia Opportunities of Bridging Studies in Asia for Global Development CONFIRMED: Patrecia Valone, Senior Director, Development Operations, Takeda Development Center Asia and Takeda Shanghai Development Center Lucitanib, A FGFR, VEGFR, PDGFR Inhibitor in Solid Tumor Introduction of Haihe, A translation/clinical development platform Our collaboration with Servier-the develop of lucitanib - trial in Europe - trial in China CONFIRMED: Lei Jiang, CEO, Shanghai HaiHe Pharmaceutical Co., Ltd Exhibition Room: The Atrium
8 Afternoon Refreshments Practical Considerations For Benefit-Risk Assessments Benefit risk evolves throughout the life-cycle of a drug Signal detection is an ongoing process where no single method will meet all needs and all circumstances All potential signals need to be documented, systematically investigated, and appropriately addressed Pharmaceutical companies cannot effectively monitor the safety of their products without the close cooperation of Health Authorities, healthcare professionals and patients An effective risk management system is the key to maximizing patient benefits while minimizing their risk CONFIRMED: Wei Wang, Associate Director, Safety Surveillance and Risk Management, Pfizer China Research & Development Center, China Managing Pharmacovigilance and Patient Safety Practices for Global Studies, given Ethic and Regulatory Differences CONFIRMED: Ming Ji, Sr. Medical Director, Medical Safety Evaluation, AbbVie End of Conference
2014 Event Sponsors: For more information please contact marketing@oxfodglobalasia.com
Oxford Global Conferences are proud to present the 3 rd Annual Clinical Trials & Outsourcing Asia Congress and 4 th Annual Pharma R&D Asia Congress to be held on the 27 th & 28 th February 2014 in Shanghai,
More informationMain Conference Agenda
Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental
More informationTHE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
More informationSusmita Gupta, Sr. CDM Project Manager, Endo Pharmaceuticals, USA
March 4-5 2013, Morristown, NJ, USA www.clinical-trials-events.com/chinausa.html www.clinical-trials-events.com/asiausa.html The 5th China and Asia Clinical Trials Outsourcing Congress Asia has the fastest
More informationClinical Trials Asia Summit 2010
19, 20, August 2010, Taj Residency (M.G. Road), Bangalore, India "Improving clinical practice & trial success rates with improved technologies, strategies & alliance management" Key Speakers Include: Akhilesh
More informationBiometrics: Clinical Trials and Beyond
Biometrics: Clinical Trials and Beyond Statistics, Programming, and Data Management in Research, Development, and Regulatory Submissions. For all, Not Just Statisticians! Keynote Presentations Sue-Jane
More informationClinical Trials OUTSOURCING & DEVELOPMENT
Clinical Trials OUTSOURCING & DEVELOPMENT 2-3 rd December Singapore A clinical partnering event for outsourcing and development professionals and service providers in late phase clinical trials DRAFT AGENDA
More informationCHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
More informationAccelerating Drug & Clinical Trial Approvals in China & East Asia
25 28 March 2014 The Westin Beijing Chaoyang, Accelerating Drug & Clinical Trial Approvals in & East Asia What s New in 2014? Key Regulatory Update from the National Institute for Food & Drug Control,
More information6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
More informationTo know more about Pharmacovigilance and Clinical Trials Data Management
To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding
More informationJoin our scientific talent community
Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into
More informationWhat Lies Ahead? Trends to Watch: Health Care Product Development in North America
What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the
More information3rd Annual Patient Recruitment & Retention in Pharma
Amsterdam, 23rd - 24th February 2011 3rd Annual Patient Recruitment & Retention in Pharma Who will I meet there? Chairperson Liz Moench President and CEO MediciGlobal Wolfgang Eglmeier Head Clinical Operations
More informationSafety Is Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies
Safety Is Global: Contemporary Pharmacovigilance and Medical Product Risk Management Strategies CLICK HERE to register. PROGRAM COMMITTEE WHO SHOULD ATTEND This program will benefit professionals with
More information2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit
2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit Addressing the most critical issues facing China s pharma & life science sector 10 th & 11 th April, 2014 Shanghai China
More informationOutsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation
More informationBayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups
Open Innovation@BayerHealthCare Dr. Daniel Forler External Innovation Therapeutics Global Drug Discovery, Bayer HealthCare ASTP-Proton Conference Page 1 Bayer Invests Heavily in R&D and is committed to
More informationA Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations
A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations Ce3, Inc. and Insight Genetics, Inc. Oncology Forum July 15, 2015 Agenda Introductions Definitions Regulations
More informationSmall-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
More informationQuality by Design Concept
3rd Jerusalem Conference on Quality and Pharma Sciences 6-7 June, 2012 QbD in Clinical Research - Where Can QbD Impact Clinical Research Practices? Dr. Yafit Stark Vice President, TEVA Pharmaceutical Industries,
More informationIn-depth analysis of the report is based on propriety databases, primary and secondary research and inhouse analysis by a team of experts.
Brochure More information from http://www.researchandmarkets.com/reports/1882193/ Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising
More informationLocation for Trials- Global Considerations A Pharma Perspective. Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014
Location for Trials- Global Considerations A Pharma Perspective Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014 Why Choose Australia for Clinical Trials? What is he saying
More informationStrategic Consulting Services
Services 1 Leadership Team Mark Levonyak President mlevonyak@davaonc.com Mobile: 214.460.5051 Martin W. Lee, MD EVP, Clinical Trial Services mlee@davaonc.com Mobile: 952.373.1405 John Eckardt, MD Chief
More informationThe Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014
The Role of Regional Medical Advisor (RMA)-Field Medical Dr. Aju Abraham Varghese Pfizer India Feb 22 nd 2014 Disclaimer The opinions expressed in this presentation are solely those of the presenter and
More informationIntroduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure
Policy Issues in the Economics and Financing of Medical Technology in the Asia-Pacific Region Dr KAI HONG PHUA Joint Professor Yong Loo Lin School of Medicine and Lee Kuan Yew School of Public Policy National
More informationKEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
More informationGroundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
More informationDevelopment of CDISC Tuberculosis Data Standards
Development of CDISC Tuberculosis Data Standards Michael Fiola Senior Director / Quintiles The presenters have disclosed that they have no proprietary or financial interests in the topics covered in this
More information2015 / 2016 Awards Criteria and Submission Information
9 th Annual ViE Awards 2015 / 2016 Awards Criteria and Submission Information In association with: Dear colleague, The Vaccine Industry Excellence (ViE) Awards have been created to honor and generate recognition
More informationPharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595
Transparency Market Research Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample Published Date:
More informationOracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be
More informationThe Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals
The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical
More informationSpring 2013. From Our CEO. Special Event WuXi Forum - Gateway to China Chinese Premier Li Keqiang Visits WuXi Headquarter in Shanghai
From Our CEO Special Event WuXi Forum - Gateway to China Chinese Premier Li Keqiang Visits WuXi Headquarter in Shanghai Featured Story WuXi and PRA Form Joint Venture to Offer Clinical Research Services
More informationJOHN REID PhD, MBA. (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1
JOHN REID PhD, MBA (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1 PROFILE Senior-level business development and licensing executive with a well-honed ability to translate scientific
More informationAPAC CRO Market A deep dive into the trends transforming APAC CRO industry. P86A-52 June 2015
APAC CRO Market A deep dive into the trends transforming APAC CRO industry June 2015 Table of Contents Section Slide Numbers Executive Summary 10 Key Findings 11 Total CRO Market Size By Stages of Clinical
More informationPROVENTA INTERNATIONAL INNOVATION. Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products
INNOVATION SPOTLIGHT SESSION Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products WEDNESDAY 4TH NOVEMBER 2015 Hyatt Regency, Princeton, NJ PROVENTA INTERNATIONAL
More informationCLINICAL DEVELOPMENT OPTIMIZATION
PAREXEL CLINICAL RESEARCH SERVICES CLINICAL DEVELOPMENT OPTIMIZATION Enhancing the clinical development process to achieve optimal results ADVANCED TECHNOLOGY COMBINED WITH INTELLIGENT THINKING CAN HELP
More informationPharmaceutical Quality & Clinical Research Quality: The Interaction
4 th Jerusalem Conference: Quality by Design (QbD)) & Pharma Sciences, May 20-22, 2014 The Edmund Safra Campus, The Hebrew University of Jerusalem Pharmaceutical Quality & Clinical Research Quality: The
More informationLIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO. @LSQld
LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO @LSQld LEADING DESTINATION FOR CLINICAL RESEARCH INVESTORS IN QLD INCLUDE: LIFE SCIENCES IN QLD ~300 companies in life sciences ~$5B invested by
More informationInvestment summit supports Australian biotech industry to attract investment and grow
Investment summit supports Australian biotech industry to attract investment and grow During 2014, more than $500 million in investment was raised for Australian biotech. A Scientific American survey of
More informationDIA 2016. 52 ND Annual Meeting. Exhibitor Prospectus
DIA 2016 52 ND Annual Meeting MEETING DATES: JUNE 26-30, 2016 EXHIBIT DATES: JUNE 27-29, 2016 Pennsylvania Convention Center Philadelphia, PA Exhibitor Prospectus Join the who s who in the life sciences
More informationBIG DATA BREATHES LIFE INTO NEXT-GEN PHARMA R&D
www.wipro.com BIG DATA BREATHES LIFE INTO NEXT-GEN PHARMA R&D Dr.Sarika Vanarse Principal Consultant Pharma R&D, Industry Solutions Group Table of Contents 03... Abstract 03... Introduction 05... Preparing
More informationLife Science Sector Opportunities Northern Ireland. Clinical Trials. investni.com
Life Science Sector Opportunities Northern Ireland investni.com Introduction Clinical trials commonly refer to testing the effectiveness of experimental drugs and are typically categorised into four phases;
More informationIn the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
More informationSafety Risk Management Company Perspective
Safety Risk Management Company Perspective Akihisa Harada, MD, Ph.D VP, Development Japan Pfizer Japan Inc. R&D Head Club Agenda REMS in FDAAA Safety Risk Management throughout a Drug s Lifecycle Risk
More informationCommitted to innovation and growth
Committed to innovation and growth Alan Hippe, CFO Roche Group London, September 2012 This presentation contains certain forward-looking statements. These forward-looking statements may be identified by
More informationClinical trials in haemophilia
Clinical trials in haemophilia Dr. Paul Giangrande Oxford Haemophilia and Thrombosis Centre & Nuffield Department of Clinical Medicine University of Oxford paul.giangrande@ndm.ox.ac.uk Why do clinical
More informationBIOCLINICA, INC. TO DEMONSTRATE TECHNOLOGY-ENHANCED CAPABILITIES AT UPCOMING GLOBAL INDUSTRY EVENTS
Company Contact - Jim Dorsey BioClinica, Inc. 267-757-3040 Trade Media Morgan Dub Karpo Diccicco Battista Communications 484-342-3600 FOR IMMEDIATE RELEASE BIOCLINICA, INC. TO DEMONSTRATE TECHNOLOGY-ENHANCED
More informationROOT CAUSE ANALYSIS. Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from Clinical to Post-Market
5th SIGNAL DETECTION, ROOT CAUSE ANALYSIS & January 22-23, 2015 Key Bridge Marriott Arlington, VA Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from
More informationGlobal Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
More informationHarmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge
Harmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge Master of Applied Clinical and Preclinical Research macpr.osu.edu Consortium of Academic Programs
More informationImplication of China 2012 NEDL. Presented by: Li Xingwei Yong Hueyling
Implication of China 2012 NEDL to MNC pharma players Presented by: Li Xingwei Yong Hueyling Content Brief introduction of China NEDL policy China hospital system & MNCs Business Focus Influence of 2012
More informationRegulatory Affairs Graduate & Postgraduate Program. Novartis Pharma AG Novartis Animal Health AG
Regulatory Affairs Graduate Postgraduate Program Novartis Pharma AG Novartis Animal Health AG The Regulatory Affairs (RA) Graduate Program is an opportunity to discover the global functions of Drug Regulatory
More informationEnabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV
Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Maria Isaac, MASc, MD, PhD, MFPM, Psychiatrist Senior Scientific Officer Institute
More informationHow To Understand And Understand Biosimilars
Welcome to Biosimilars 20/20, presented by the Specialty Pharma Education Center (SPEC) in partnership with the Specialty Pharma Journal (SPJ). Please note that this is a preliminary agenda that is subject
More informationBlockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com
More informationSPEAKER BIOGRAPHICAL INFORMATION
SPEAKER BIOGRAPHICAL INFORMATION Madeleine R. Valera MD, MScIH (Heidelberg) Dr. Valera is a senior health care service professional with over 20 years of professional expertise in Health Financing and
More informationAchieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013
Achieving Regulatory Success: Areas of focus for biotechnology companies Michael J. Schlosser, PhD, DABT April 21, 2013 Regulatory Success Outline Regulatory Initiatives Regulatory Science Pre-Regulatory
More informationBrochure More information from http://www.researchandmarkets.com/reports/3292678/
Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long
More informationAnnual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
More informationThe Top 10 Contract Research Organizations
OUTSOURCING The Top 10 Contract Research Organizations Positioning, performance and SWOT analyses Table of Contents Copyright 2009 Business Insights Ltd This Management Report is published by Business
More informationEthics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient
More informationMedical Writing Takes Off in India
Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com
More informationPharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a
More informationU.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010
U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction
More informationACC San Diego Chapter
ACC San Diego Chapter Biomedical and Technology Collaborations with Chinese Companies: Legal and Cultural Challenges October 2012 DLA Piper Overview Our Firm 4,200 lawyers in 77 offices and 33 countries
More informationThe Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry
Talentmark Consulting Product Driven People Solutions Press Release The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Cambridge
More informationPANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14
PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14 March 5-6, 2014 Princeton, NJ The Nassau Inn Identify, Prioritize and Solve Key Operational Challenges that Shape the Customer Experience in Pharma GOLD SPONSORS
More informationMasters Learning mode (Форма обучения)
Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)
More informationDrug Development Models in China and the Impact on Multinational Pharmaceutical Companies
Drug Development Models in China and the Impact on Multinational Pharmaceutical Companies By Ling Su, Ph.D. China represents a huge potential opportunity for the pharmaceutical industry in both commercial
More informationA PROVEN APPROACH to ACCELERATED CLINICAL DEVELOPMENT
Accelovance 2275 Research Boulevard, Suite 700 Rockville, MD 20850, United States Phone: +1.240.238.4900 Fax: +1.240.238.4901 Internet: www.accelovance.com email: gsmith@accelovance.com Contact Person:
More informationPresented at: Jefferies 2015 Global Healthcare Conference
Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution
More informationTime and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management
Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Reference Code: GBIHC088MR Publication Date: June 2011 Biopharmaceutical companies
More informationNMRC Awards Ceremony and Research Symposium 2014 Grand Copthorne Waterfront Hotel, Singapore 26-27 February 2014
DAY 1 26 February 2014 (Wednesday) Morning Session TIME PROGRAMME 0815 0850 REGISTRATION 0900 0930 WELCOME ADDRESS OPENING ADDRESS by Guest-of-Honour, PS(Health) AWARDS PRESENTATION Translational Research
More informationOutcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
More informationAnnual Report on Form 20-F
Annual Report on Form 20-F 2 Teva at a Glance Founded in 1901 by three young pharmacists, today Teva Pharmaceutical Industries Ltd. is a leader in the global pharmaceutical industry, providing medicines
More informationFuture roles and opportunities for statisticians in pharmaceutical industry
Future roles and opportunities for statisticians in pharmaceutical industry H. Ulrich Burger 1), Stefan Driessen 2), Chrissie Fletcher 3), Michael Branson 4), Christoph Gerlinger 5) 1) Hoffmann-La Roche
More information2 Day Seminar Assuring Data Integrity in the Life Science industry
2 Day Seminar Assuring Data Integrity in the Life Science industry Location 1: Boston Sep 08 09 Hilton Garden Inn Boston Logan Airport 100 Boardman Street, Boston, MA 02128 Hotel: 617-567- 6789 Location
More informationA leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
More informationPharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
More informationRichard T. Clark Chief Executive Officer and President. Executing on Our Strategy
Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS
More informationClinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.
Clinical Trial Trends Outline Complexity for Supply Chain Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.com 29 May 2013 Biotechnology Sales on the Rise Source: EvaluatePharma
More informationRx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
More informationBuilding innovative drug discovery alliances. Profitable. Growth Go
Building innovative drug discovery alliances Innovation n & Profitable Growth Go Evotec AG, H1 Presentation, 8 th August 2012 Forward-looking statements Information set forth in this presentation contains
More informationCLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD
CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD Gwen L. Nichols, M.D., is currently the Oncology Site Head of the Roche Translational Clinical Research Center at Hoffman- LaRoche. In this
More informationGlobal Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
More informationCONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW
CONTRACT RESEARCH ORGANIZATION INDUSTRY OVERVIEW April 2014 Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams
More informationINTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS
INTERNATIONAL PHARMACEUTICAL PRIVACY CONSORTIUM COMMENTS IN RESPONSE TO THE CALL FOR EVIDENCE ON EU DATA PROTECTION PROPOSALS I. INTRODUCTION The International Pharmaceutical Privacy Consortium (IPPC)
More informationThe Clinical Trials Process an educated patient s guide
The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-
More informationPG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management
PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management Contact: +91 9886735658, 080 28411665 ext 5103 Email: crtraining@avesthagen.com PG Diploma In Clinical Research,
More informationClinical Supply Chain Management. Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management
Clinical Supply Chain Management Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management GBI Research Report Guidance GBI Research Report Guidance The report focuses on the current
More informationThe Cell Therapy Catapult
The Cell Therapy Catapult Keith Thompson CEO January 29 2013 info@ct.catapult.org.uk Catapult is a Technology Strategy Board programme The Launch of Catapults Hauser 2 Hauser Report Creating new manufacturing
More informationPRODUCT RESEARCH & DEVELOPMENT PROCESS
0 :: 2 v01 x y p.345 B xxx.:: B A x y pval«««[xy] -løøøø xxx.:: øøøø -0.02-0.01-0.00 0.00 0.01 0.02.1.2 A PHARMATRAIN CENTRE OF EXCELLENCE INTRODUCTORY MODULE: PRODUCT RESEARCH & DEVELOPMENT PROCESS Aveiro
More informationLater-Stage Development: Ensuring Compliance During. for a Competitive Advantage Webinar Series
Part II: Later-Stage Development: Ensuring Compliance During Clinical i l Trials Process Driven Compliance for a Competitive Advantage Webinar Series 29 September 2010 Process Driven Compliance Webinar
More informationGuidance for Industry
Guidance for Industry End-of-Phase 2A Meetings U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 Procedural Guidance
More informationClinical Trial Supply Europe 2016 Barcelona, 2 nd & 3 rd March 2016 2016 SPEAKERS INCLUDE
Clinical Trial Supply Europe 2016 Barcelona, 2 nd & 3 rd March 2016 2016 SPEAKERS INCLUDE Jan-Pieter Kappelle, Senior Director, Global Clinical Trial Supplies, UCB Didier Basseras, Vice President, Clinical
More informationBiosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies
Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Fern Barkalow, Ph.D, Senior Analyst, Oncology Citeline One of the biggest challenges facing biosimilar drug developers is
More informationClinical Trials Patient Experience Summit
Clinical Trials Patient Experience Summit How Connected Patient-Driven Initiatives are Improving Clinical Trial Productivity April 7-8, 2016 Sheraton Palo Alto Palo Alto, CA Day One, April 7 th 8:00 8:50
More information9th-10th April 2015 Shanghai China 2015 年 4 月 9-10 日 中 国 上 海. New. Hosted & Organized by. Supported by. M e d i a 2 0 1 4
9th-10th April 2015 Shanghai China 2015 年 T rai n i n g T h e New G en e r a t io n Hosted & Organized by Supported by BACKGROUND A shortage of airline pilots is threatening China s hopes of building a
More information